Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>CICC: ALI HEALTH (00241.HK) TP Lifted to $7.1 as Strengthened Strategic Co-op with Upstream Firms to Expand Biz
Recommend 7 Positive 5 Negative 5 |
||||
|
||||
|
ALI HEALTH (00241.HK)'s 1HFY26 results for the period ended September beat CICC's expectations, with a revenue of RMB16.697 billion, up 17% YoY, and a non-GAAP net profit of RMB1.356 billion, up 38.7% YoY, corresponding to a profit margin of 8.1%, mainly due to the strong performance of the original prescription drug category, according to CICC's research report. The broker also anticipated that the Company's continued strengthening of strategic partnerships with upstream enterprises will aid in expanding contributions from businesses other than product sales. Considering the Company's consistent profit generation, CICC raised its FY2026/ 2027 non-GAAP net profit forecasts for the Company by 16%/ 16% to RMB2.48 billion/ RMB2.75 billion, respectively. Taking into account the recent uplift in sector valuations, the broker lifted its target price by 30% to $7.1 based on SOTP valuation, with rating kept at Outperform. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
